← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Therion Biologics Corporation
Cambridge, MA
$747,224
Total funding
6
Grants
Funding mix
By agency
NIH$747,224 · 6
By mechanism
P01$668,712 · 4
N01$78,512 · 2
Investigators at Therion Biologics Corporation
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
COMBINED VACCINE STRATEGIES FOR THE PREVENTION OF AIDS$2,198,847
P01 · FY2002 · AI
COMBINED VACCINE STRATEGIES FOR THE PREVENTION OF AIDS$1,660,208
P01 · FY2000 · AI
COMBINED VACCINE STRATEGIES FOR THE PREVENTION OF AIDS$1,576,586
P01 · FY2001 · AI
COMBINED VACCINE STRATEGIES FOR THE PREVENTION OF AIDS$1,126,760
P01 · FY2003 · AI
COMBINED VACCINE STRATEGIES FOR THE PREVENTION OF AIDS$428,756
P01 · FY2001 · AI
NOVEL VIRAL VECTORS FOR AIDS VACCINES$167,178
P01 · FY2000 · AI
HIV 1 CELLULAR AND HUMORAL IMMUNE RESPONSES$167,178
P01 · FY2000 · AI
POXVIRUS BASED AIDS VACCINES$167,178
P01 · FY2000 · AI
RECOMBINANT POXVIRUS ELICITED CYTOTOXIC T LYMPHOCYTES IN MONKEYS$167,178
P01 · FY2000 · AI
HIV VACCINE PRODUCTION$78,512
N01 · FY2000 · AI
HIV 1 CELLULAR AND HUMORAL IMMUNE RESPONSES$0
P01 · FY2002 · AI
RECOMBINANT POXVIRUS ELICITED CYTOTOXIC T LYMPHOCYTES IN MONKEYS$0
P01 · FY2002 · AI
POXVIRUS BASED AIDS VACCINES$0
P01 · FY2002 · AI
HIV 1 CELLULAR AND HUMORAL IMMUNE RESPONSES$0
P01 · FY2001 · AI
HIV VACCINE PRODUCTION$0
N01 · FY2000 · AI
RECOMBINANT POXVIRUS ELICITED CYTOTOXIC T LYMPHOCYTES IN MONKEYS$0
P01 · FY2001 · AI
HIV 1 CELLULAR AND HUMORAL IMMUNE RESPONSES$0
P01 · FY2001 · AI
NOVEL VIRAL VECTORS FOR AIDS VACCINES$0
P01 · FY2001 · AI
NOVEL VIRAL VECTORS FOR AIDS VACCINES$0
P01 · FY2002 · AI
POXVIRUS BASED AIDS VACCINES$0
P01 · FY2001 · AI